ConductScience.org, home

Paper40161336

EGCG's anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through in vitro investigation.

Khair AMB and 3 others. PeerJ, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. EGCG's anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through in vitro investigation. Papers, record 40161336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40161336

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EGCG's anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through in vitro investigation.
PubMed
Journal
PeerJ
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-05-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khair AMBAl Moutassem Billah
2Maniangat Luke AAlexander
3Patnaik RRajashree
4Testarelli LLuca

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CatechinMajor topic
ApoptosisMajor topic
Lung NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Humans
Proto-Oncogene Proteins c-akt
Cell Proliferation
Signal Transduction
Cell Line, Tumor
Cell Movement
A549 Cells
Phosphatidylinositol 3-Kinases

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137446908Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.Molecules2023https://conductscience.org/library/papers/37446908PubMed
231938038Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge.Infect Agent Cancer2020https://conductscience.org/library/papers/31938038PubMed
331013611Radioprotective Effect of Walnut Oligopeptides Against Gamma Radiation-Induced Splenocyte Apoptosis and Intestinal Injury in Mice.Molecules2019https://conductscience.org/library/papers/31013611PubMed
424366444Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway.Oncol Rep2014https://conductscience.org/library/papers/24366444PubMed
533650320Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.Cancer Med2021https://conductscience.org/library/papers/33650320PubMed
630058690Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway.Eur Rev Med Pharmacol Sci2018https://conductscience.org/library/papers/30058690PubMed
732020598Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries.Int J Cancer2020https://conductscience.org/library/papers/32020598PubMed
834769263Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/34769263PubMed
932008337Epigallocatechin gallate reduces uric acid levels by regulating xanthine oxidase activity and uric acid excretion in vitro and in vivo.Ann Palliat Med2020https://conductscience.org/library/papers/32008337PubMed
1037762316An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC.Int J Mol Sci2023https://conductscience.org/library/papers/37762316PubMed
1129989449New options on the horizon for nononcogene addicted non-small-cell lung cancer.Future Oncol2018https://conductscience.org/library/papers/29989449PubMed
1229791813Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.N Engl J Med2018https://conductscience.org/library/papers/29791813PubMed
1337445915The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment.Int J Mol Sci2023https://conductscience.org/library/papers/37445915PubMed
1438552205Chemical Scaffolds for the Clinical Development of Mutant-Selective and Reversible Fourth-Generation EGFR-TKIs in NSCLC.ACS Chem Biol2024https://conductscience.org/library/papers/38552205PubMed
1529332333Epigallocatechin gallate from green tea exhibits potent anticancer effects in A-549 non-small lung cancer cells by inducing apoptosis, cell cycle arrest and inhibition of cell migration.J BUON2017https://conductscience.org/library/papers/29332333PubMed
1623711146PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.Am J Chin Med2013https://conductscience.org/library/papers/23711146PubMed
1726794417EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation.Oncol Rep2016https://conductscience.org/library/papers/26794417PubMed
1838543009Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.Molecules2024https://conductscience.org/library/papers/38543009PubMed
1931777584Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082.J Cancer2019https://conductscience.org/library/papers/31777584PubMed
2036500365Induction of Apoptosis via Inactivating PI3K/AKT Pathway in Colorectal Cancer Cells Using Aged Chinese Hakka Stir-Fried Green Tea Extract.Molecules2022https://conductscience.org/library/papers/36500365PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42793131Epigallocatechin Gallate Modulates the Cellular Response to Doxorubicin in HeLa Cervical Cancer Cells.Biomolecules2026https://conductscience.org/library/papers/42793131PubMed
41674940EGCG promotes apoptosis in BT-549 triple-negative breast cancer cells by targeting STAT3.Transl Cancer Res2026https://conductscience.org/library/papers/41674940PubMed
40871008Lipid-Based Nanotechnologies for Delivery of Green Tea Catechins: Advances, Challenges, and Therapeutic Potential.Pharmaceutics2025https://conductscience.org/library/papers/40871008PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40161336

GET https://conductscience.org/api/papers/v1/40161336/references?page=2